Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated safety and efficacy ...
Prelude Therapeutics Incorporated (Nasdaq: PRLD) (“Prelude” or the “Company”), a clinical-stage precision oncology company, ...
Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious ...
The 83rd Annual Meeting of the Highland Soil and Water Conservation District (SWCD) was held Oct. 15 at Backroom Paradise.
Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that clinical data on rusfertide in polycythemia ...
1d
Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting
Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic ...
Join us at APHA 2025 to explore the benefits of collaboration. Come see APLPH for engaging sessions and discussions.
The Green Bay Packers are preparing to welcome several thousand of the organization's shareholders to attend the Annual Meeting of Shareholders, set for Friday, July 25, at 3 p.m. at Lambeau Field.
Canton Heritage Center hosts its 10th annual meeting Nov. 13 with a special look at 1925 time capsule artifacts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback